Mechanistic Models of COVID-19: Insights into Disease Progression, Vaccines, and Therapeutics.

Authors:
Desikan R; Padmanabhan P; Kierzek AM; van der Graaf PH.

Journal:
Int J Antimicrob Agents

Publication Year: 2022

DOI:
10.1016/j.ijantimicag.2022.106606

PMCID:
PMC9110059

PMID:
35588969

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Antimicrob Agents

Abbreviation: Int J Antimicrob Agents

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis.
Chang YC; Chen YC; Huang CC and 7 more (2023) - Transparency Score: 4/6
Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis o…
Tian F; Feng Q; Chen Z. (2023) - Transparency Score: 4/6
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-ass…
Russo A; Bruni A; Gullì S and 12 more (2023) - Transparency Score: 3/6
Prescription of antibiotics by general practitioners for patients with a diagnosis of SARS- CoV-2 i…
Diamantis S; Youbong T; Strazzulla A and 7 more (2023) - Transparency Score: 3/6
The battle against fungi: lessons in antifungal stewardship from COVID 19 times
Kanj SS; Haddad SF; Meis JF and 9 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests R.D. was a former employee, and A.M.K., P.H.v.d.G. are current employees of Certara QSP who were involved in the development of Certara's vaccine QSP model. All the authors declare no conflict of interest."

Evidence found in paper:

"Funding No funding."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025